The Calanolides, a Novel HIV-inhibitory Class of Coumarin Derivatives from the Tropical Rainforest Tree, Calophyllum lanigerum

Journal of Medicinal Chemistry

Volumn 35, Issue 15, 1992, Pages 2735-2743

  Gustafson, Kirk R ^a   Fuller, Richard W ^a   Cardellina, John H ^a   McMahon, James B ^a   Currens, Michael J ^a   Boyd, Michael R ^a   Kashman, Yoel ^a   Buckheit, Robert W ^b   Hughes, Stephen H ^a   Cragg, Gordon M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CALANOLIDE A; CALANOLIDE B; CALANOLIDE C; CALANOLIDE DERIVATIVE; COUMARIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG SPECIFICITY; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; TREE; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CHROMATOGRAPHY, LIQUID; COUMARINS; CYTOPATHOGENIC EFFECT, VIRAL; DRUG RESISTANCE, MICROBIAL; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HIV-2; HUMAN; HYDROLYSIS; MAGNETIC RESONANCE SPECTROSCOPY; REVERSE TRANSCRIPTASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, U.S. GOV'T, P.H.S.; TREES; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 0026647540     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00093a004     Document Type: Article

References (36)

1. Boyd, M. R. Strategies for the identification of new agents for the treatment of AIDS: A national program to facilitate the discovery and preclinical development of new drug candidates for clinical evaluation. In AIDS Etiology, Diagnosis, Treatment and Prevention; Devita, V. T., Jr., Heilman, S., Rosenberg, S. A., Eds.; Lippincott: Philadelphia, 1988; pp 305-319.
2. Gustafson, K. R.; Munro., H. G.; Blunt, J. W.; Cardellina, J. H., II; McMahon, J. B.; Gulakowski, R. J.; Cragg, G. M.; Cox, P. A.; Brinen, L. S.; Clardy, J.; Boyd, M. R. HIV inhibitory natural products. 3. Diterpenes from Homalanthus acuminatus and Chrysobalanus icaco. Tetrahedron 1991, 47, 4547-4554.
3. Gustafson, K. R.; Cardellina, J. H., II; McMahon, J. B.; Gulakowski, R. J.; Ishitoya, J.; Szallasi, Z.; Lewin, N. E.; Blumberg, P. M.; Weislow, O. S.; Beutler, J. A.; Buckheit, R. W., Jr.; Cragg, G. M.; Cox, P. A.; Bader, J. P.; Boyd, M. R. A nonpromoting phorbol from the Samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1. J. Med. Chem. 1992 35 1978-1986.
4. Manfred'i, K. P.; Blunt, J. W.; Cardellina, J. H., II; McMahon, J. B.; Pannell, L. K.; Cragg, G. M.; Boyd, M. R. Novel alkaloids from the tropical plant, Ancistrocladus abbreviatus, inhibit cell killing by HIV-1 and HIV-2. J. Med. Chem. 1991, 34, 3402-3405.
5. Beutler, J. A.; Cardellina, J. H., II; McMahon, J. B.; Cragg, G. M.; Boyd, M. R. Anti-HIV and cytotoxic alkaloids from Buchenavia capitata. J. Nat. Prod. 1992, 55, 207-213.
6. Gustafson, K. R.; Cardellina, J. H., II; McMahon, J. B.; Pannell, L. K.; Cragg, G. M.; Boyd, M. R. The peltatols, novel HIV inhibitory catechol derivatives from Pothomorphe peltata. J. Org. Chem. 1992, 57, 2809-2811.
7. Dharmaratne, H. R. W.; Sotheeswaran, S.; Balasubramaniam, S.; Reisch, J. Xanthones from roots of three Calophyllum species. Phytochemistry 1986, 25, 1957-1959.
8. Kumar, V.; Sotheeswaran, S.; Surendrakumar, S.; Balasubramaniam, S. Calocalabaxanthone, the putative isoprenyl precursor of calabaxanthone from Calophyllum calaba. Phytochemistry 1982, 21, 807-809.
9. Somanthan, R.; Sultanbawa, M. U. S. Chemical investigation of Ceylonese plants. Part VIII, Trapezifolixanthone, a new di-isoprenylated xanthone from the bark of Calophyllum trapezifolium Thw. (Guttiferae). J. Chem. Soc. Perkin Trans. 1 1974, 2515-2517.
10. Gunasekera, S. P.; Sultanbawa, M. U. S. Chemical investigation of Ceylonese plants. Part XVI. Extractives of Calophyllum cordatooblongum Thw. (Guttiferae). J. Chem. Soc. Perkin Trans. 1 1975, 2215-2220.
11. Gunatilaka, A. A. L.; De Silva, A. M. Y. J.; Sotheeswaran, S.; Balasubramaniam, S.; Wazeer, M. I. M. Terpenoid and biflavonoid constituents of Calophyllum calaba and Garcinia spicata from Sri Lanka. Phytochemistry 1984, 23, 323-328.
12. Dahanayake, M.; Kitagawa, I.; Somanathan, R.; Sultanbawa, M. U. S. Chemical investigation of Ceylonese plants. Part VII. Extractives of Calophyllum thwaitesii Planch and Triana and Calophyllum walkeri Wight (Guttiferae). J. Chem. Soc. Perkin Trans. 1 1974, 2510-2514.
13. Samaraweera, U.; Sotheeswaran, S.; Sultanbawa, M. U. S. Calozeylanic acid, a new bark acid from three Calophyllum species (Guttiferae). Tetrahedron Lett. 1981, 22, 5083-5086.
14. Gautier, J.; Kunesch, G.; Polonsky, J. Structure of calophynic acid, a novel constituent of Calophyllum inophyllum. Tetrahedron Lett. 1972, 2715-2718.
15. Stout, G. H.; Sears, K. D. Calophyllum products. III. The structure of blancoic acids. J. Org. Chem. 1968,33,4185-4190.
16. Weislow, O. S.; Kiser, R.; Fine, D. L.; Bader, J.; Shoemaker, R. H.; Boyd, M. R. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J. Natl. Cancer Inst. 1989, 81, 577-586.
17. Grode, S. H.; James, T. R.; Cardellina, J. H., II; Onan, K. D. Molecular structures of the briantheins, new insecticidal diterpenes from Briareum polyanthes. J. Org. Chem. 1983,48, 5203-5207.
18. Stout, G. H.; Stevens, K. L. The structure of costatolide. J. Org. Chem. 1964, 29, 3604-3609.
19. Ohtani, I.; Kusumi, T.; Ishitsuka, M. O.; Kakisawa, H. Absolute configurations of marine diterpenes possessing a xenicane skeleton. An application of an advanced Mosher's method. Tetrahedron Lett. 1989, 30, 3147-3150.
20. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. A new aspect of the high-field NMR application of Mosher's method. The absolute configuration of marine triterpene sipholenol-A. J. Org. Chem. 1991, 56, 1296-1297.
21. Gulakowski, R. J.; McMahon, J. B.; Staley, P. G.; Moran, R. A.; Boyd, M. R. A semiautomated multiparameter approach for anti-HIV drug screening. J. Virol. Methods 1991, 33, 87-100.
22. Rink, T. J.; Tsien, R. Y.; Pozzan, T. Cytoplasmic pH and free Mg2+ in lymphocytes. J. Cell. Biol. 1982, 95, 189-196.
23. McCaffrey, T. A.; Agarwal, L. A.; Weksler, B. B. A rapid fluorometric DNA assay for the measurement of cell density and proliferation in vitro. In Vitro Cell. Dev. Biol. 1988, 24, 247-252.
24. Connolly, J. J.; Hammer, S. M. Antiretroviral therapy: Reverse transcriptase inhibition. Antimicrob. Agents Chemother. 1992, 36, 245-254.
25. Pauwels, R.; Andries, K.; Desmyter, J.; Schols, D.; Kukla, M. J.; Breslin, H. J.; Raeymaeckers, A.; VanGelder, J.; Woestenborghs, R.; Heykants, J.; Schellekens, K.; Janssen, M. A. C.; DeClercq E.; Janssen, P. A. J. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 1990, 343, 470-474.
26. Koup, R. A.; Merluzzi, V. J.; Hargrave, K. D.; Adams, J.; Grozinger, K.; Eckner, R. J.; Sullivan, J. L. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587. J. Infect. Dis. 1991, 163, 966-970.
27. Goldman,M. E.; Nunberg, J. H.; O'Brien, J. A.; Quintero, J. C.; Schleif, W. A.; Freund, K. F.; Gaul, S. L.; Saari, W. S.; Wai, J. S.; Hoffman, J. M.; Anderson, P. S.; Hupe, D. J.; Emini, E. A.; Stern, A. M. Pyridinone derivatives: Specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity. Proc. Natl. Acad. Sci. U.S.A. 1991,88, 6863-6867.
28. Nunberg, J. H.; Schleif, W. A.; Boots, E. J.; O'Brien, J. A.; Quintero, J. C.; Hoffman, J. M.; Emini, E. A.; Goldman, M. E. Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors. J. Virol. 1991, 65, 4887-4892.
29. DeClercq, E. HIV inhibitors targeted at the reverse transcriptase. AIDS Res. Hum. Retroviruses 1992, 8, 119-134.
30. Hizi, A.; McGill, C.; Hughes, S. H. Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 1218-1222.
31. Clark, P. K.; Ferris, A. L.; Miller, D. A.; Hizi, A.; Kim, K. W.; Deringer-Boyer, S. M.; Mellini, M. L.; Clark, A. D., Jr.; Arnold, G. F.; Lebherz, W. B., III; Arnold, E.; Muschik, G. M.; Hughes, S. H. HIV-1 reverse transcriptase purified from a recombinant strain of Escherichia coli. AIDS Res. Hum. Retroviruses 1990, 6, 753-764.
32. Hizi, A.; Hughes, S. H.; Shaharabany, M. Mutational analysis of the ribonuclease H activities of human immunodeficiency virus 1 reverse transcriptase. Virology 1990, 175, 575-580.
33. White, E. L.; Buckheit, R. W.; Ross, L. J.; Germany, J. M.; Andries, K.; Pauwels, R.; Janssen, P. A. J.; Shannon, W. M.; Chirigos, M. A. A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates. Antiviral Res. 1991, 16, 257-266.
34. Larder, B. A.; Darby, G.; Richman, D. D. HIV with reduced sensitivity to Zidovadine (AZT) isolated during prolonged therapy. Science 1989, 243, 1731-1734.
35. Merigan, T. C. Treatment of AIDS with combinations of antiretroviral agents. Am. J. Med. 1991,90 (Suppl. 4A), 4A-8S, 4A-175.
36. Buckheit, R. W., Jr.; Swanstrom, R. Characterization of an HIV-1 isolate displaying an apparent absence of virion-associated reverse transcriptase activity. AIDS Res. Hum. Retroviruses 1991, 7, 295-302.